Literature DB >> 28948971

Purinergic system in psychiatric diseases.

A Cheffer1, A R G Castillo1, J Corrêa-Velloso1, M C B Gonçalves2, Y Naaldijk1, I C Nascimento1, G Burnstock3,4, H Ulrich1.   

Abstract

Psychiatric disorders are debilitating diseases, affecting >80 million people worldwide. There are no causal cures for psychiatric disorders and available therapies only treat the symptoms. The etiology of psychiatric disorders is unknown, although it has been speculated to be a combination of environmental, stress and genetic factors. One of the neurotransmitter systems implicated in the biology of psychiatric disorders is the purinergic system. In this review, we performed a comprehensive search of the literature about the role and function of the purinergic system in the development and predisposition to psychiatric disorders, with a focus on depression, schizophrenia, bipolar disorder, autism, anxiety and attention deficit/hyperactivity disorder. We also describe how therapeutics used for psychiatric disorders act on the purinergic system.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28948971     DOI： 10.1038/mp.2017.188

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


  236 in total

1.  Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals.

Authors:  R A Cunha
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

2.  Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments.

Authors:  Janusz Borycz; M Fátima Pereira; Alessia Melani; Ricardo J Rodrigues; Attila Köfalvi; Leigh Panlilio; Felicita Pedata; Steven R Goldberg; Rodrigo A Cunha; Sergi Ferré
Journal:  J Neurochem       Date:  2007-01-24       Impact factor: 5.372

Review 3.  Adenosine and autism: a spectrum of opportunities.

Authors:  Susan A Masino; Masahito Kawamura; Jessica L Cote; Rebecca B Williams; David N Ruskin
Journal:  Neuropharmacology       Date:  2012-08-24       Impact factor: 5.250

4.  Adenosine A1 receptors modulate anxiety in CD1 mice.

Authors:  C Florio; A Prezioso; A Papaioannou; R Vertua
Journal:  Psychopharmacology (Berl)       Date:  1998-04       Impact factor: 4.530

5.  P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder.

Authors:  Susanne Lucae; Daria Salyakina; Nicholas Barden; Mario Harvey; Bernard Gagné; Michel Labbé; Elisabeth B Binder; Manfred Uhr; Marcelo Paez-Pereda; Inge Sillaber; Marcus Ising; Tanja Brückl; Roselind Lieb; Florian Holsboer; Bertram Müller-Myhsok
Journal:  Hum Mol Genet       Date:  2006-07-05       Impact factor: 6.150

6.  Adenosine 5'-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo.

Authors:  U Krügel; H Kittner; P Illes
Journal:  Neurosci Lett       Date:  1999-04-09       Impact factor: 3.046

7.  Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder.

Authors:  Nicholas Barden; Mario Harvey; Bernard Gagné; Eric Shink; Monique Tremblay; Catherine Raymond; Michel Labbé; André Villeneuve; Denis Rochette; Lise Bordeleau; Herbert Stadler; Florian Holsboer; Bertram Müller-Myhsok
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-06-05       Impact factor: 3.568

8.  Association analysis of adenosine A1 receptor gene (ADORA1) polymorphisms with schizophrenia in a Japanese population.

Authors:  Leo Gotoh; Hiroshi Mitsuyasu; Yuki Kobayashi; Naoya Oribe; Atsushi Takata; Hideaki Ninomiya; Vincent P Stanton; Gregory M Springett; Hiroaki Kawasaki; Shigenobu Kanba
Journal:  Psychiatr Genet       Date:  2009-12       Impact factor: 2.458

9.  Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania.

Authors:  Rodrigo Machado-Vieira
Journal:  J Clin Psychopharmacol       Date:  2012-10       Impact factor: 3.153

10.  Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory.

Authors:  Anna G Orr; Edward C Hsiao; Max M Wang; Kaitlyn Ho; Daniel H Kim; Xin Wang; Weikun Guo; Jing Kang; Gui-Qiu Yu; Anthony Adame; Nino Devidze; Dena B Dubal; Eliezer Masliah; Bruce R Conklin; Lennart Mucke
Journal:  Nat Neurosci       Date:  2015-01-26       Impact factor: 24.884
View more
  46 in total

Review 1.  Hyperinflammation and airway surface liquid dehydration in cystic fibrosis: purinergic system as therapeutic target.

Authors:  Thiago Inácio Teixeira do Carmo; Victor Emanuel Miranda Soares; Jonatha Wruck; Fernanda Dos Anjos; Débora Tavares de Resende E Silva; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini
Journal:  Inflamm Res       Date:  2021-04-27       Impact factor: 4.575

2.  Gene expression and response prediction to amisulpride in the OPTiMiSE first episode psychoses.

Authors:  Réjane Troudet; Wafa Bel Haj Ali; Delphine Bacq-Daian; Inge Winter van Rossum; Anne Boland-Auge; Christophe Battail; Caroline Barau; Dan Rujescu; Philip McGuire; René S Kahn; Jean-François Deleuze; Marion Leboyer; Stéphane Jamain
Journal:  Neuropsychopharmacology       Date:  2020-05-25       Impact factor: 7.853

3.  Astrocytic equilibrative nucleoside transporter type 1 upregulations in the dorsomedial and dorsolateral striatum distinctly coordinate goal-directed and habitual ethanol-seeking behaviours in mice.

Authors:  Sa-Ik Hong; Amanda Bullert; Matthew Baker; Doo-Sup Choi
Journal:  Eur J Neurosci       Date:  2020-05-13       Impact factor: 3.386

4.  Indirect Medium Spiny Neurons in the Dorsomedial Striatum Regulate Ethanol-Containing Conditioned Reward Seeking.

Authors:  Sa-Ik Hong; Seungwoo Kang; Jiang-Fan Chen; Doo-Sup Choi
Journal:  J Neurosci       Date:  2019-07-17       Impact factor: 6.167

5.  Type 1 equilibrative nucleoside transporter (ENT1) regulates sex-specific ethanol drinking during disruption of circadian rhythms.

Authors:  Yun-Fang Jia; Chelsea A Vadnie; Ada Man-Choi Ho; Lee Peyton; Marin Veldic; Katheryn Wininger; Aleksey Matveyenko; Doo-Sup Choi
Journal:  Addict Biol       Date:  2019-07-02       Impact factor: 4.280

6.  Zinc.

Authors:  Anatoly V Skalny; Michael Aschner; Alexey A Tinkov
Journal:  Adv Food Nutr Res       Date:  2021-05-24

7.  Fibroblast growth factor 2 upregulates ecto-5'-nucleotidase and adenosine deaminase via MAPK pathways in cultured rat spinal cord astrocytes.

Authors:  Ryota Eguchi; Taisuke Kitano; Ken-Ichi Otsuguro
Journal:  Purinergic Signal       Date:  2020-10-06       Impact factor: 3.765

8.  P2X7 Receptors Drive Poly(I:C) Induced Autism-like Behavior in Mice.

Authors:  Gergely Horváth; Lilla Otrokocsi; Katinka Beko; Mária Baranyi; Ágnes Kittel; Pablo Antonio Fritz-Ruenes; Beáta Sperlágh
Journal:  J Neurosci       Date:  2019-01-25       Impact factor: 6.167

9.  Reactivity of salivary uric acid in response to social evaluative stress in African Americans.

Authors:  Todd Lucas; Jenna L Riis; Zachary Buchalski; Caroline E Drolet; Anurag Dawadi; Douglas A Granger
Journal:  Biol Psychol       Date:  2020-03-24       Impact factor: 3.251

10.  Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice.

Authors:  Molly A Kwiatkowski; Benjamin Z Roberts; Jordy van Enkhuizen; Baohu Ji; Xianjin Zhou; Jared W Young
Journal:  Eur Neuropsychopharmacol       Date:  2020-11-13       Impact factor: 4.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.